1. Home
  2. SRDX vs WENN Comparison

SRDX vs WENN Comparison

Compare SRDX & WENN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRDX
  • WENN
  • Stock Information
  • Founded
  • SRDX 1979
  • WENN 2025
  • Country
  • SRDX United States
  • WENN United States
  • Employees
  • SRDX N/A
  • WENN N/A
  • Industry
  • SRDX Medical/Dental Instruments
  • WENN
  • Sector
  • SRDX Health Care
  • WENN
  • Exchange
  • SRDX Nasdaq
  • WENN Nasdaq
  • Market Cap
  • SRDX 415.4M
  • WENN 387.9M
  • IPO Year
  • SRDX 1998
  • WENN 2025
  • Fundamental
  • Price
  • SRDX $35.41
  • WENN $10.23
  • Analyst Decision
  • SRDX Buy
  • WENN
  • Analyst Count
  • SRDX 2
  • WENN 0
  • Target Price
  • SRDX $43.00
  • WENN N/A
  • AVG Volume (30 Days)
  • SRDX 209.2K
  • WENN 45.3K
  • Earning Date
  • SRDX 08-12-2025
  • WENN 01-01-0001
  • Dividend Yield
  • SRDX N/A
  • WENN N/A
  • EPS Growth
  • SRDX N/A
  • WENN N/A
  • EPS
  • SRDX N/A
  • WENN N/A
  • Revenue
  • SRDX $121,575,000.00
  • WENN N/A
  • Revenue This Year
  • SRDX N/A
  • WENN N/A
  • Revenue Next Year
  • SRDX $3.19
  • WENN N/A
  • P/E Ratio
  • SRDX N/A
  • WENN N/A
  • Revenue Growth
  • SRDX N/A
  • WENN N/A
  • 52 Week Low
  • SRDX $26.00
  • WENN $10.30
  • 52 Week High
  • SRDX $41.32
  • WENN $11.91
  • Technical
  • Relative Strength Index (RSI)
  • SRDX 64.76
  • WENN N/A
  • Support Level
  • SRDX $34.64
  • WENN N/A
  • Resistance Level
  • SRDX $38.10
  • WENN N/A
  • Average True Range (ATR)
  • SRDX 1.48
  • WENN 0.00
  • MACD
  • SRDX 0.20
  • WENN 0.00
  • Stochastic Oscillator
  • SRDX 65.50
  • WENN 0.00

About SRDX Surmodics Inc.

Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.

About WENN Wen Acquisition Corp Class A Ordinary Shares

Wen Acquisition Corp is a blank check company.

Share on Social Networks: